Hepatitis B reactivation in patients with multiple myeloma and isolated positive hepatitis B core antibody: a call for greater cognizance.
作者： Ju Dong Yang , Mohit Girotra , Alejandro Restrepo , Sarah Waheed , Bart Barlogie
DOI: 10.1016/S1665-2681(19)30855-5
关键词:
摘要: Hepatitis B virus (HBV) reactivation is a well-established complication of severe immunosuppression in patients with hematologic malignancy and positive hepatitis surface antigen (HBsAg). Patients who receive high-dose chemotherapy, corticosteroids, rituximab, or have bone marrow transplant are particularly at increased risk for HBV reactivation. However, limited information available the literature regarding isolated anti-HBc, setting multiple myeloma (MM). We report two cases MM anti-HBc rather atypical presentation. In conclusion, our highlight that clinicians need to be cognizant about this potentially fatal but preventable chemotherapy immunosuppression.
elsevier.es参考文章(19)
Silvia Park, Kihyun Kim, Dong Hwan Kim, Jun Ho Jang, Seok Jin Kim, Won Seog Kim, Chul Won Jung, Kwang Cheol Koh, Changes of hepatitis B virus serologic status after allogeneic hematopoietic stem cell transplantation and impact of donor immunity on hepatitis B virus. Biology of Blood and Marrow Transplantation. ,vol. 17, pp. 1630- 1637 ,(2011) , 10.1016/J.BBMT.2011.04.006
Tatsuya Yoshida, Shigeru Kusumoto, Atsushi Inagaki, Fumiko Mori, Asahi Ito, Masaki Ri, Takashi Ishida, Hirokazu Komatsu, Shinsuke Iida, Fuminaka Sugauchi, Yasuhito Tanaka, Masashi Mizokami, Ryuzo Ueda, Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports International Journal of Hematology. ,vol. 91, pp. 844- 849 ,(2010) , 10.1007/S12185-010-0592-Y
Anna SF Lok, Brian J McMahon, None, Chronic hepatitis B: Update 2009 Hepatology. ,vol. 50, pp. 661- 662 ,(2009) , 10.1002/HEP.23190
Anna SF Lok, John W Ward, Robert P Perrillo, Brian J McMahon, T Jake Liang, None, Reactivation of hepatitis B during immunosuppressive therapy: potentially fatal yet preventable. Annals of Internal Medicine. ,vol. 156, pp. 743- 745 ,(2012) , 10.7326/0003-4819-156-10-201205150-00013
R. Lee, K. Vu, C.M. Bell, L. K. Hicks, Screening for hepatitis B surface antigen before chemotherapy: current practice and opportunities for improvement Current Oncology. ,vol. 17, pp. 32- 38 ,(2010) , 10.3747/CO.V17I6.653
George K.K Lau, Harry H.Y Yiu, Daniel Y.T Fong, Hoi-Ching Cheng, Wing-Yan Au, Lydia S.F Lai, Micheal Cheung, Hai-Ying Zhang, Albert Lie, Roger Ngan, Raymond Liang, Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy Gastroenterology. ,vol. 125, pp. 1742- 1749 ,(2003) , 10.1053/J.GASTRO.2003.09.026
Sung-Nan Pei, Ming-Chun Ma, Ming-Chung Wang, Ching-Yuan Kuo, Kun-Min Rau, Cheng-Yu Su, Chien-Hung Chen, Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy Annals of Hematology. ,vol. 91, pp. 1007- 1012 ,(2012) , 10.1007/S00277-012-1405-6
Jay H. Hoofnagle, Reactivation of Hepatitis B Hepatology. ,vol. 49, ,(2009) , 10.1002/HEP.22945
Rohit Loomba, Ayana Rowley, Robert Wesley, T. Jake Liang, Jay H. Hoofnagle, Frank Pucino, Gyorgy Csako, Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Annals of Internal Medicine. ,vol. 148, pp. 519- 528 ,(2008) , 10.7326/0003-4819-148-7-200804010-00008
Annemarie Wasley, Deanna Kruszon‐Moran, Wendi Kuhnert, Edgar P. Simard, Lyn Finelli, Geraldine McQuillan, Beth Bell, The Prevalence of Hepatitis B Virus Infection in the United States in the Era of Vaccination The Journal of Infectious Diseases. ,vol. 202, pp. 192- 201 ,(2010) , 10.1086/653622